Annual report pursuant to Section 13 and 15(d)

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)

v3.22.1
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES    
Incentive compensation $ 504,000 $ 850,000
Accounts payable 1,415,000 1,429,000
Clinical study costs 1,881,000 787,000
Professional fees 54,000 221,000
Other 1,000 156,000
Accounts Payable and Accrued Liabilities, Current, Total $ 3,854,914 $ 3,443,197